Afyren SAS Enters New Phase with Continuous Production at AFYREN NEOXY

Afyren SAS, a company specializing in the production of biobased organic acids, has marked a significant milestone in its industrial strategy. On June 17, 2025, Afyren announced the achievement of continuous production at its first plant, AFYREN NEOXY. This development is a pivotal step in the company’s efforts to scale up its production capabilities and accelerate commercialization.

Key Developments and Achievements

The continuous industrial operation of all process stages at AFYREN NEOXY has been validated over recent weeks, marking the beginning of an industrial ramp-up phase. This achievement allows the company to produce hundreds of tons of bio-based acids, which are already being commercialized. Afyren has secured €165 million in revenue through contracts, which are set to be executed in the coming years.

Strategic Objectives and Future Plans

Afyren has outlined its short and medium-term objectives, aiming to achieve significant production revenue in 2025, estimated in the low single-digit million euros range. The company also targets achieving plant break-even within a few quarters. Looking ahead, Afyren plans to build and operate three plants in a sequential manner, leveraging the success of AFYREN NEOXY. This strategy includes an intermediary debottlenecking project to enhance production efficiency.

Financial and Market Context

As of June 15, 2025, Afyren’s close price was €2.66, with a market capitalization of €68,669,539. The company’s stock has experienced fluctuations over the past year, reaching a 52-week high of €3.45 on August 28, 2024, and a low of €1.475 on January 26, 2025. Afyren operates in the Materials sector and is listed on the NYSE Euronext Paris, with its financials denominated in EUR.

Sustainability and Circular Economy

Afyren’s production process is notable for its sustainability, as it utilizes agricultural byproducts as feedstock. The residue from the fermentation-based process is sold as organic fertilizer, completing a circular process that underscores the company’s commitment to environmental responsibility.

In summary, Afyren’s achievement of continuous production at AFYREN NEOXY represents a significant advancement in its industrial strategy, setting the stage for increased production and commercialization of its biobased products. The company’s strategic plans and financial outlook position it for continued growth in the materials sector.